Tom Coats
7PUBLICATIONS
26CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (7)
Sort by Publication Date:
|Nov 14, 2025
CPX-351 vs daunorubicin, cytarabine, and gemtuzumab ozogamicin in older adults with non-adverse-risk AML: the NCRI AML18 trial.Steven Knapper, Laura W Dillon, Malavika Babu
|Jul 18, 2024
Impact of patient demographics on treatment outcomes in AML: a population-based registry in England, 2013-2020.Hanhua Liu, Simon J Stanworth, Sean McPhail
|Jul 08, 2024
CREST-UK: Real-world effectiveness, safety and outpatient delivery of CPX-351 for first-line treatment of newly diagnosed therapy-related AML and AML with myelodysplasia-related changes in the UK.Priyanka Mehta, Victoria Campbell, Jamie Maddox
|Mar 11, 2024
Capture-based targeted sequencing using a T-cell control in myeloid malignancies and idiopathic cytopenias.Grzegorz Pietka, Corinne De Lord, Gwynn Matthias
|Jul 18, 2022
An open-source, expert-designed decision tree application to support accurate diagnosis of myeloid malignancies.Thomas Coats, Daniel Bean, Theodora Vatopoulou
Pageof 2
Frequent Collaborators
3 joint publications
Priyanka Mehta
2 joint publications
Mike Dennis
2 joint publications
Anjum B Khan
1 joint publications
Nigel Russell
1 joint publications
Richard Dillon
1 joint publications
Henry Wood
1 joint publications
David Tucker
1 joint publications
Mary Frances McMullin
1 joint publications
Nicholas Cross
1 joint publications
David Taussig